Clinical trials abroad – balancing innovation, care, and cost

When international patients travel for medical treatment, the stakes are already high. But when the treatment involves a cutting-edge clinical trial, the complexity multiplies financially, logistically, and reputationally. This was the challenge faced by a European insurer whose member was approved for travel to Seattle, in the US state of Washington, to participate in a PLAT immunotherapy trial for cancer.

The challenges

The patient’s case presented several critical hurdles:

• Media scrutiny: The case was closely followed in Germany, where journalists monitored the patient’s treatment and the insurer’s handling of costs and care

• Financial barriers: The US hospital required a substantial upfront deposit before care could begin

• Poor network leverage: The hospital’s discounts with major networks were minimal at less than 15%, leaving the client exposed to significant costs

• Ongoing oversight: With weeks of hospitalisation, and the media coverage, the client needed frequent updates and ongoing bill review to maintain transparency.

For the insurer, there was no room for missteps. Every decision would be measured not only in dollars saved, but also in patient outcomes and public perception.

NFG’s approach

NFG mobilised its arbitration, bill auditing, and care management teams to address the unique circumstances. First, we leveraged direct hospital relationships to negotiate on behalf of the client, securing nearly 50% savings compared to billed charges – over three times the standard network discount.

Recognising the reputational pressures, NFG also arranged for pre-payment of deposits to ensure seamless admission, while setting up a structured billing cadence with the hospital. Instead of a single large invoice at discharge, NFG obtained regular, itemised bills, which allowed for proactive auditing and alignment with the patient’s treatment plan.

Beyond financial management, NFG worked closely with the hospital case manager to provide accurate and ongoing medical updates, ensuring the client had timely information to share with stakeholders and the media. This integration of financial and clinical oversight and transparency gave the insurer confidence that both costs and care quality were under control.

Results

The final outcome was a remarkable 47.63% in savings, far exceeding typical network discounts. More importantly, the patient received uninterrupted access to pioneering treatment in the US, with superior clinical outcomes. The insurer was able to demonstrate fiscal responsibility and compassionate support under public scrutiny.

NFG also addressed an unexpected challenge: during the hospitalisation, a family member developed depression. Rather than leaving the issue unaddressed, NFG coordinated psychiatric treatment at the same facility, allowing the family to stay close together, while receiving appropriate care.

Lessons learned

This case illustrates the multi-dimensional nature of international cost containment. It is not only about negotiating numbers, but also about anticipating the ripple effects of high-profile, complex cases. 

By integrating arbitration, auditing, clinical updates, and even family support, NFG delivered a holistic solution that balanced patient needs, insurer expectations, and public perception.

In these high-stakes cases, every detail matters. We don’t just focus on reducing the bill; we also focus on the patient’s journey, the insurer’s reputation, and the family’s wellbeing. True cost management means creating confidence across all of these fronts.

In the end, NFG helped transform what could have been a reputational and financial liability, into a showcase of human-centred, strategically managed international care.